Trial intelligence / Profile preview

NXN-188 for Acute Treatment of Migraine with Aura

NCT00877838Phase 2Unknown

Sponsor
Dansk Hovedpinecenter
Start
May 2009
Primary completion
Mar 2010
Countries
1
01

Overview

A Phase 2 trial of NXN-188 in migraine with aura, sponsored by Dansk Hovedpinecenter. Status: unknown.

02

Drugs

NXN-188
03

Conditions

migraine with aura

Beyond the preview

Go deeper on NCT00877838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00877838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call